Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2010
12/28/2010US7858641 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes
12/28/2010US7858633 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/28/2010US7858631 such as (3R,5S)-N-(3-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-7-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used as melanocortin-4 receptor (MC4-R) agonists, for the treatment of obesity or diabetes
12/28/2010US7858624 such as methyl 2-((R)-((R)-1-((2S,3S)-5-(butylamino)-1-cyclohexyl-3-hydroxy-5-oxopentan-2-ylcarbamoyl)piperidin-3-yl)(3-chlorophenyl)methoxy)ethylcarbamate, used as hypotensive agents or for the treatment of cardiovascular disorders, vision defects, aldosteronism and obesity
12/28/2010US7858622 calcitonin gene related peptide antagonists such as [(3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-[4-[1-(3-ethoxy-3-oxopropyl)piperidin-4-yl]piperidin-1-yl]-1-oxopropan-2-yl]4-(3-oxo-5-phenyl-1H-1,2,4-triazol-2-yl)piperidine-1-carboxylate; headaches; diabetes; irritable bowel syndrome; hot flashes
12/28/2010US7858621 Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
12/28/2010US7858619 Improved solubility, lower tendency to bind to plasma proteins and greater activity especially in serum-based assay systems; remodeling of heart after myocardial infarction; atherosclerosis; 2-[4-(4-Fluorophenoxy)benzenesulfonyl]-6-(2-piperidin-1-ylethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid
12/28/2010US7858615 (S)-(-)-1-(4-fluoroisoquinolin-5-Yl)Sulfonyl-2-methyl-1,4-homopiperazine hydrochloride dihydrate
12/28/2010US7858614 Therapeutic pyrazolonaphthyridine derivatives
12/28/2010US7858211 Organic electroluminescent device
12/23/2010WO2010148314A2 Preparation of esomeprazole and its pharmaceutically acceptable salts
12/23/2010WO2010147917A1 Disubstituted phthalazine hedgehog pathway antagonists
12/23/2010WO2010147302A2 Novel intermediates of voriconazole and preparation method of voriconazole using the same
12/23/2010WO2010146881A1 Substituted isoquinoline derivative
12/23/2010WO2010146488A1 Bicyclic and tricyclic compounds as kat ii inhibitors
12/23/2010WO2010146428A1 An improved process for the preparation of rabeprazole
12/23/2010WO2010146395A1 Pyrazine carboxamides as inhibitors of dgat1
12/23/2010WO2010146236A1 Urea substituted sulphonamide derivatives
12/23/2010WO2010146083A1 Anthelmintic agents and their use
12/23/2010WO2010145186A1 Peptide deformylase inhibitor containing 2,5-dihydropyrrole and synthesis method thereof
12/23/2010WO2010128528A3 Piperidine derivatives useful for treatment of diebetes
12/23/2010WO2010126626A3 Dual mechanism inhibitors for the treatment of disease
12/23/2010WO2010091876A3 Small molecule bradykinin b1 receptor antagonists
12/23/2010WO2009133572A3 Process for the preparation of amorphous raberazole sodium
12/23/2010US20100324298 Novel Process for the Preparation of Esomeprazole and Salts Thereof
12/23/2010US20100324297 Method for producing 1, 2-dihydropyridine-2-one compound
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/23/2010US20100324092 Pyridyl and pyrimidinyl derivatives as histone deacetylase inhibitors
12/23/2010US20100324091 Pyrazolone Derivative
12/23/2010US20100324088 Fused Pyridone M1 Receptor Positive Allosteric Modulators
12/23/2010US20100324084 Urea derivatives of tropane, their preparation and their therapeutic application
12/23/2010US20100324076 Novel sEH Inhibitors and their Use
12/23/2010US20100324070 Indole, indazole and benzimidazole arylamides as p2x3 and p2x2/3 antagonists
12/23/2010US20100324066 Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same
12/23/2010US20100324064 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
12/23/2010US20100324061 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
12/23/2010US20100324058 thrombin function compounds and pharmaceutical compositions based on them
12/23/2010US20100324053 Trisubstituted 1,2,4 triazoles
12/23/2010US20100324049 Diaryl ketimine derivative having antagonism against melanin-concentrating hormone receptor
12/23/2010US20100324048 Disubstituted phthalazine hedgehog pathway antagonists
12/23/2010US20100324046 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/23/2010US20100324045 Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/23/2010US20100324043 Bicyclic And Tricyclic Compounds As KAT II Inhibitors
12/23/2010US20100324042 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
12/23/2010US20100324030 5-Quinoline derivatives having an anti-bacterial activity
12/23/2010US20100324028 Novel compounds
12/23/2010US20100324025 Antibacterial Agents
12/23/2010US20100324024 Quinolizidinone M1 Receptor Positive Allosteric Modulators
12/23/2010US20100324017 Acylguanidine derivative
12/23/2010US20100324016 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
12/23/2010US20100324015 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
12/23/2010US20100324013 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324012 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324011 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324010 Amide compounds and use of the same
12/23/2010US20100324009 Substituted Sulfonamide Compounds
12/23/2010US20100323965 Thrombopoietin Mimetics
12/23/2010US20100323887 Mesoionic pesticides
12/23/2010US20100322980 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
12/23/2010US20100322901 5, 6-ring annulated indole derivatives and use thereof
12/23/2010CA2765130A1 Anthelmintic agents and their use
12/23/2010CA2764542A1 Disubstituted phthalazine hedgehog pathway antagonists
12/23/2010CA2764124A1 Substituted isoquinoline derivative
12/23/2010CA2764013A1 Pyrazine carboxamides as inhibitors of dgat1
12/23/2010CA2763960A1 Bicyclic and tricyclic compounds as kat ii inhibitors
12/22/2010EP2264032A2 Hiv protease inhibiting sulfonamides
12/22/2010EP2264030A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2264026A1 Alkylaminopyridine derivative
12/22/2010EP2264025A1 Method to produce a crystalline form of compounds (II')
12/22/2010EP2264024A1 Process for the preparation of enantiomerically enriched proton pump inhibitors
12/22/2010EP2264023A1 Method for producing pyrimidine compound
12/22/2010EP2264022A1 Cyano anthranilamide insecticides
12/22/2010EP2264021A1 Process for producing an anthranilamide compound
12/22/2010EP2264014A1 Substituted pyridazines as anti-inflammatory agents and protein kinase inhibitors
12/22/2010EP2264009A1 Pyridylaminoacetic acid compound
12/22/2010EP2263672A1 Novel pharmaceutically acceptable salts of 4-(1H-imidazol-4-ylmethyl)pyridine and their therapeutical uses
12/22/2010EP2262795A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof
12/22/2010EP2262794A1 Sulfonamide compounds and their use as fungicide
12/22/2010EP2262793A2 Nilotinib hci crystalline forms
12/22/2010EP2262792A1 Substituted sulfonamide derivatives
12/22/2010EP2262791A2 Substituted sulfonamide derivatives
12/22/2010EP2262790A1 Crystal of benzimidazole compound
12/22/2010EP2262789A1 2-aminoquinolines
12/22/2010EP2262778A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxcr1 and p40
12/22/2010EP2262777A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cri
12/22/2010EP2262773A1 2-aminoquinoline derivatives
12/22/2010EP2262772A1 Quinoline derivatives as axl kinase inhibitors
12/22/2010EP2262771A1 A method for the preparation of dabigatran
12/22/2010EP2262770A1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
12/22/2010EP2262767A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
12/22/2010EP2094684B1 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin 2-ones as cb1 receptor modulators
12/22/2010EP2061774B1 Arylpiperazine derivatives and uses thereof
12/22/2010EP1915345B1 Fluoro substituted 2-oxo azepan derivatives
12/22/2010EP1784396B1 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
12/22/2010EP1758869B1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
12/22/2010EP1453805B1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
12/22/2010CN1988907B Dual small molecule inhibitors of cancer and angiogenesis
12/22/2010CN1886380B Benzoimidazole compounds
12/22/2010CN1812973B Indazole compounds useful as protein kinase inhibitors
1 ... 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 ... 1080